Robert Nutbrown

MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

Debashis Sarker, Ruth Plummer, Tim Meyer et al. · Clinical Cancer Research · 2020 · 175 citations · Full text

Medicine, Oncology, Pharmacology +17

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study

Kenneth R. Chapman, Kai Michael Beeh, Jutta Beier et al. · BMC Pulmonary Medicine · 2014 · 84 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

CD19 4-1BBL (RO7227166) a Novel Costimulatory Bispecific Antibody Can be Safely Combined with the T-Cell-Engaging Bispecific Antibody Glofitamab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Martin Hutchings, Carmelo Carlo‐Stella, Giuseppe Gritti et al. · Blood · 2022 · 23 citations

Pharmacy, Immunology, Oncology +16